Gene-Tailored treatment shows promise for rare lung disease
Disease control
Completed
This study tested whether adding N-acetylcysteine (NAC) to standard care helps people with idiopathic pulmonary fibrosis (IPF) who have a specific gene variant (TOLLIP TT). The goal was to see if NAC could delay lung function decline, hospital stays, or death. 202 adults with IPF…
Phase: PHASE3 • Sponsor: Fernando J Martinez • Aim: Disease control
Last updated May 07, 2026 18:41 UTC